Factor VIIa: Difference between revisions

David Canner (talk | contribs)
No edit summary
No edit summary
Line 1: Line 1:
{{STRUCTURE_1dan| PDB=1dan| SCENE= }}
[[Image:1dan.png|left|200px|thumb|Crystal Structure of Human factor VIIa complex with
Factor VIIa (FVIIa)is a single chain trypsin-like serine protease [http://en.wikipedia.org/wiki/Serine_protease](EC 3.4.21.21) of 406 residues. The FVII[http://en.wikipedia.org/wiki/Factor_VIIa] zymogen is a glycoprotein consisting of an amino-terminal (N-linked) γ-carboxyglutamic acid (Gla)[http://en.wikipedia.org/wiki/Carboxyglutamic_acid]domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains, a short linker peptide, and a carboxy terminal serine protease domain<ref>PMID:10430872</ref>. The active form, FVIIa, is generated by a specific cleavage of a peptide bond between Arg152 and Ile153 at the end of the linker peptide by either factor Xa (FXa) or thrombin (IIa). This cleavage generates an N-terminal light chain of 152 residues linked to a heavy chain of 254 residues by a disulfide bridge <ref>PMID:6778860</ref>. Following cleavage the newly formed N-terminal inserts itself into a cavity, or the activation pocket, forming a salt bridge with Asp343 (Asp194 trypsin numbering).Formation of this salt bridge allows for the maturation of FVIIa to its active form.
tissue factor and a peptide inhibitor, [[1dan]]]]
{{STRUCTURE_1dan| PDB=1dan | SIZE=300| SCENE= |right|CAPTION=Human factor VIIa complex with
tissue factor and a peptide inhibitor, [[1dan]] }}
 
[[Factor VIIa]] (FVIIa)is a single chain trypsin-like serine protease [http://en.wikipedia.org/wiki/Serine_protease](EC 3.4.21.21) of 406 residues. The FVII[http://en.wikipedia.org/wiki/Factor_VIIa] zymogen is a glycoprotein consisting of an amino-terminal (N-linked) γ-carboxyglutamic acid (Gla)[http://en.wikipedia.org/wiki/Carboxyglutamic_acid]domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains, a short linker peptide, and a carboxy terminal serine protease domain<ref>PMID:10430872</ref>. The active form, FVIIa, is generated by a specific cleavage of a peptide bond between Arg152 and Ile153 at the end of the linker peptide by either factor Xa (FXa) or thrombin (IIa). This cleavage generates an N-terminal light chain of 152 residues linked to a heavy chain of 254 residues by a disulfide bridge <ref>PMID:6778860</ref>. Following cleavage the newly formed N-terminal inserts itself into a cavity, or the activation pocket, forming a salt bridge with Asp343 (Asp194 trypsin numbering).Formation of this salt bridge allows for the maturation of FVIIa to its active form. The images at the left and at the right correspond to one representative Factor VIIa, ''i.e.'' the crystal structure of Human factor VIIa complex with tissue factor and a peptide inhibitor ([[1dan]]).
 


==FVIIa mechanism==
==FVIIa mechanism==
Line 54: Line 59:


[[Image:catalytic domain.jpg|center]]
[[Image:catalytic domain.jpg|center]]
== 3D Structures of Factor VIIa ==
1klj – hVIIa - human
1f7e, 1f7m, 1ff7, 1ffm, 1bf9 – hVIIa EGF-like domain - NMR
Factor VIIa inhibitor complex
1cvw - hVIIa + EG-ARM
2bz6, 1w7x, 1w8b, 1ygc, 1kli - hVIIa + inhibitor
1qfk - hVIIa + DPN-FR
Factor VIIa cofactor complex
2c4f - hVIIa precursor + tissue factor
3ela - hVIIa (mutant) + tissue factor
Factor VIIa cofactor, inhibitor ternary complex
2zzu, 2zwl, 2zp0, 2ec9, 2flr, 2aei, 2aer, 2f9b, 2b7d, 1wv7, 1wun, 1wtg, 1wss, 1wqv, 1w2k, 1z6j, 1w0y – hVIIa + tissue factor + inhibitor
2puq, 2fir, 2b8o, 1dan - hVIIa + tissue factor + peptide-CMK
1j9c - hVIIa + tissue factor + FFR-methylene
2a2q - hVIIa + tissue factor + cations
1jbu - hVIIa + tissue factor + peptide exosite inhibitor
1dva - hVIIa + tissue factor + peptide exosite inhibitor + DPN-FR
1fak - hVIIa + tissue factor + BPTI (mutant)


==Additional Resources==
==Additional Resources==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Jolanta Amblo, David Canner, Alexander Berchansky, Michal Harel